This survey of more than 500 atrial fibrillation patients, ages 65+ from across the nation, revealed diagnosis and treatment experiences, information on anticoagulant use, stroke and bleeding risk discussions with health care professionals, and more.  It was conducted as part of the AFib Optimal Treatment Task Force.

You can also read the FULL RESULTS.